Genuva Semax Vail 10mg Lyophilized Powder

Genuva Semax 10mg is a research-grade synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro), an ACTH(4-10) analogue supplied as lyophilized powder. Each vial contains 10mg of high-purity peptide verified by RP-HPLC (≥97%). Semax is studied for its role in BDNF upregulation, neuroprotection, and cognitive function research . For laboratory research use only. Available now at Beast Muscle Egypt with fast domestic shipping.

Product Overview
Genuva Semax 10mg Lyophilized Powder represents a premium research-grade formulation of the synthetic heptapeptide Semax. This compound is an analogue of the N-terminal fragment (4-10) of adrenocorticotropic hormone (ACTH), consisting of the sequence Met-Glu-His-Phe-Pro-Gly-Pro . Unlike natural ACTH, Semax is completely devoid of hormonal activity, making it a valuable tool for neuroscience and neuropharmacology research .

Scientific Background and Research Applications
Semax has been extensively studied in preclinical research for its effects on neurotrophic factor expression and neuroprotection. Key research findings include:
BDNF Upregulation: Research demonstrates that Semax administration results in rapid increases in brain-derived neurotrophic factor (BDNF) protein levels in the rat basal forebrain, with a 1.4-fold increase observed in hippocampal BDNF protein levels . BDNF is a critical modulator of synaptic plasticity, neuronal survival, and cognitive function .
Neuroprotective Mechanisms: Studies utilizing transcriptome analysis (RNA-Seq) have revealed that Semax significantly reduces ischemia-induced gene expression disturbances, affecting thousands of differentially expressed genes associated with immune and neurosignaling pathways . Recent research identified that Semax promotes functional recovery after spinal cord injury by targeting μ-opioid receptors and regulating USP18-mediated deubiquitination .
Neurotransmitter System Modulation: Semax has been shown to positively modulate the striatal serotonergic system and enhance dopamine release when combined with stimulants in rodent models . This positions Semax as a valuable research compound for studying dopaminergic and serotonergic pathways.
Potential Research Models: Semax has been investigated in models of attention-deficit hyperactivity disorder (ADHD) and Rett syndrome, with proposed therapeutic potential based on its BDNF-modulating effects .

Reconstitution Guidelines
For research applications, Genuva Semax 10mg lyophilized powder should be reconstituted using sterile bacteriostatic water or sterile 18MΩ-cm H2O . Recommended procedure:
Allow vial to equilibrate to room temperature (10-15 minutes)
Inject sterile water slowly along the vial wall
Gently swirl to dissolve — do not shake vigorously
For intranasal research applications, further dilute to 0.1% (1 mg/mL) or 1% (10 mg/mL) in sterile normal saline
Store reconstituted solution at 2-8°C and use within 2-4 weeks

Why Choose Genuva Semax from Beast Muscle?
High Purity: Each batch verified at ≥97% purity by RP-HPLC
Research-Grade Quality: Produced under controlled conditions for reproducible laboratory result
Egypt Domestic Stock: Fast shipping throughout Egypt with no customs delays
Competitive Pricing: Direct pricing for Egyptian research institutions

Important Disclaimer
This product is sold exclusively for laboratory research purposes. It is not for human or veterinary use, not for diagnostic, therapeutic, or prophylactic applications, and not for personal consumption. Qualified researchers only.

Direction (Usage Instructions)
Intended Use: Research applications only (in vitro and preclinical models)

Reconstitution:
Reconstitute lyophilized powder with sterile bacteriostatic water or 18MΩ-cm H2O
For a 10mg vial, adding 5mL of diluent yields a 2 mg/mL concentration
Gently swirl; avoid vigorous agitation to prevent peptide aggregation
Storage After Reconstitution: 2-8°C, protected from light; use within 2-4 weeks
Important: This document does not provide human dosing guidance. Semax is not FDA-approved for any human indication .

Warning
Regulatory Status: Semax is not approved by the FDA or Egyptian Drug Authority for any human therapeutic use. The FDA has determined there is insufficient clinical information to characterize the safety profile of semax, and has proposed not adding it to the 503A Bulks List for compounding .

Safety Concerns Identified by Regulatory Authorities:
Immunogenicity Risk: Potential for aggregation and peptide-related impurities may trigger immune responses
Bleeding Risk: Preclinical evidence suggests possible antithrombotic/anticoagulant activity 

Note About BEAST MUSCLE

We always strive to update product images on our store according to the versions available to us. There may be some changes in manufacturing, packaging, components, or external appearance from the producing companies. Shipments may carry an alternative shape or a newer version than shown in our store, but this does not reduce the guarantee of quality and originality of the products. We recommend that you read the warnings and instructions for each product before use and do not rely solely on the information provided by BEAST MUSCLE.